Health, Medicine and Natural Healing 11

179,008 topics in this forum

1. In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor

   By Guest guest, March 25, 2011
   • 0 replies
   • 34 views
   • 
   • Guest
   • March 25, 2011

2. general health: caffeine

   By Guest guest, May 4, 2011
   • 0 replies
   • 28 views
   • 
   • Guest
   • May 4, 2011

3. Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

   By Guest guest, May 3, 2011
   • 0 replies
   • 33 views
   • 
   • Guest
   • May 3, 2011

4. lymphomation: treatment support tips

   By Guest guest, May 3, 2011
   • 0 replies
   • 19 views
   • 
   • Guest
   • May 3, 2011

5. FDA: On development of >1 Investigational Drugs for Use in Combination

   By Guest guest, May 3, 2011
   • 0 replies
   • 27 views
   • 
   • Guest
   • May 3, 2011

6. incidence of MDS - Is the treatment worse than the disease?

   By Guest guest, May 3, 2011
   • 0 replies
   • 24 views
   • 
   • Guest
   • May 3, 2011

7. Alpha-Lipoic Acid supplements during chemo?

   By Guest guest, May 5, 2011
   • 0 replies
   • 22 views
   • 
   • Guest
   • May 5, 2011

8. be alert for suspicious skin lesions

   By Guest guest, May 6, 2011
   • 0 replies
   • 27 views
   • 
   • Guest
   • May 6, 2011

9. Agent Selectively Targets Malignant B Cells In Chronic Leukemia, Study Shows

   By Guest guest, May 9, 2011
   • 0 replies
   • 21 views
   • 
   • Guest
   • May 9, 2011

10. Acetaminophen tied to blood cancers

    By Guest guest, May 10, 2011
    • 0 replies
    • 33 views
    • 
    • Guest
    • May 10, 2011

11. New Developments in Lymphoma/CLL - Weill Cornel blog

    By Guest guest, May 11, 2011
    • 0 replies
    • 41 views
    • 
    • Guest
    • May 11, 2011

12. Study Shows PCI-32765 Selectively Targets Malignant B Cells In Chronic Leukemia

    By Guest guest, May 12, 2011
    • 0 replies
    • 35 views
    • 
    • Guest
    • May 12, 2011

13. Phase II trial successes plummet

    By Guest guest, May 12, 2011
    • 0 replies
    • 21 views
    • 
    • Guest
    • May 12, 2011

14. Routine Surveillance PET/CT Scans?

    By Guest guest, May 12, 2011
    • 0 replies
    • 37 views
    • 
    • Guest
    • May 12, 2011

15. study: Lenalidomide and Vaccine in early-stage CLL

    By Guest guest, May 13, 2011
    • 0 replies
    • 28 views
    • 
    • Guest
    • May 13, 2011

16. 5 tips/rules for living well with a chronic illness

    By Guest guest, May 15, 2011
    • 0 replies
    • 25 views
    • 
    • Guest
    • May 15, 2011

17. Re: Phase II trial successes plummet

    By Guest guest, May 15, 2011
    • 0 replies
    • 25 views
    • 
    • Guest
    • May 15, 2011

18. CD5 Promotes IL-10 Production in Chronic Lymphocytic Leukemia B Cells through STAT3 and NFAT2 Activation

    By Guest guest, March 14, 2011
    • 0 replies
    • 29 views
    • 
    • Guest
    • March 14, 2011

19. Clinical trial: Ofatumumab + Dexamethasone

    By Guest guest, March 14, 2011
    • 0 replies
    • 38 views
    • 
    • Guest
    • March 14, 2011

20. A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.

    By Guest guest, March 16, 2011
    • 0 replies
    • 34 views
    • 
    • Guest
    • March 16, 2011

21. CAL-101 interim results

    By Guest guest, March 18, 2011
    • 0 replies
    • 27 views
    • 
    • Guest
    • March 18, 2011

22. Phase I/II Clinical Trial In CLL To Evaluate Combination Therapy With Biothera's Imprime PGG

    By Guest guest, March 18, 2011
    • 0 replies
    • 39 views
    • 
    • Guest
    • March 18, 2011

23. nanotech detection of minimal residual disease (MRD)

    By Guest guest, March 22, 2011
    • 0 replies
    • 35 views
    • 
    • Guest
    • March 22, 2011

24. Clinical Trial Design: A Tutorial for Research Advocates

    By Guest guest, May 16, 2011
    • 0 replies
    • 46 views
    • 
    • Guest
    • May 16, 2011

25. Re: CAL-101 interim results

    By Guest guest, March 18, 2011
    • 2 replies
    • 28 views
    • 
    • Guest
    • March 22, 2011